Originally Published April 9, 2018
ROCHESTER, Minn. — Patients in communities in southern Minnesota and across the state soon will have better access to new cancer treatments and enhanced care delivery, thanks to a new state-funded partnership involving the University of Minnesota, Mayo Clinic, the Hormel Institute and several of the state’s large health care providers.
As part of the Minnesota Discovery Research and InnoVation (MnDRIVE) partnership with the state of Minnesota, the University of Minnesota is launching the Minnesota Cancer Clinical Trials Network with multiple locations across the state.
Led by the Masonic Cancer Center, University of Minnesota, the Minnesota Cancer Clinical Trials Network will improve cancer outcomes for all Minnesotans through greater access to cancer clinical trials in prevention, treatment and survivorship. These trials will originate from Minnesota’s two National Cancer Institute-designated Comprehensive Cancer Centers: the Masonic Cancer Center and Mayo Clinic Cancer Center, along with the Hormel Institute in Austin.
For the full story please see the Mayo Clinic News Network